Company profile for Yuyu Pharma

Yuyu Pharma

NEW Drugs in Dev: 6

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

7 News #PharmaBuzz

media
7 News #PharmaBuzz

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, ...

Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis.

euroPLX 90 LisboneuroPLX 90 Lisbon

Not Confirmed

Not Confirmed

02-03 March, 2026

Lisbon, Portugal
BIO CEO & InvestorBIO CEO & Investor

Not Confirmed

Not Confirmed

02-03 March, 2026

Miami, U.S.A
Clinical OutsourcingClinical Outsourcing

Not Confirmed

Not Confirmed

03-04 March, 2026

Copthorne Tara Hotel, London Kensington, United Ki

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

korearepublicofnew Flag

Country

Country

South Korea

Address

Address

Yuyu Building, 197 Dongho-ro, Jung-gu, Seoul, Republic of Korea

Telephone

Telephone

02-2253-6600

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.yuyu.co.kr/en/main/main.do

Linkedin

https://www.linkedin.com/company/yuyu-pharma/?originalSubdomain=kr

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Yuyu Pharma Sets Up UCLA Office For U.S. Pet Industry Growth

14 Jan 2026

// PR NEWSWIRE

Yuyu Pharma Invests in Dalan to Boost Global Animal Health

02 Dec 2025

// PR NEWSWIRE

Yuyu Pharma to attend 'CPHI Worldwide 2023'

18 Oct 2023

// PR NEWSWIRE

Yuyu Pharma, Dry Eye Pipeline MOA & Pre-clinical Results Published

27 Apr 2023

// PR NEWSWIRE

Yuyu Pharma unveiled the results of its MOA and head-to- head studies

27 Apr 2023

// PR NEWSWIRE

Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

29 Nov 2022

// PRNEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search